Institut de recherche biomédicale
     
    Vous êtes ici : Accueil / La Recherche / Développement, Reproduction, Cancer / Equipe C. Desdouets

    Publications de l'équipe : Cycle cellulaire et physiopathologies hépatiques

    164 publication(s) trouvée(s)

    • Maillet, V., Boussetta, N., Leclerc, J., Fauveau, V., Foretz, M., Viollet, B., Couty, J. P., Celton-Morizur, S., Perret, C., Desdouets, C. LKB1 as a Gatekeeper of Hepatocyte Proliferation and Genomic Integrity during Liver Regeneration Cell Rep 2018; 22(8):1994-2005
    • Desdouets, C., Avila, M. A. Inhibiting Cytokinesis in the Liver: A New Way to Reduce Tumor Development Gastroenterology 2018; 154(5):1229-1231
    • Fortier, M., Celton-Morizur, S., Desdouets, C. Incomplete cytokinesis/binucleation in mammals: The powerful system of hepatocytes Methods Cell Biol 2017; 137:119-142
    • Celton-Morizur, S., Desdouets, C. Liver physiological polyploidization: MicroRNA-122 a key regulator Clin Res Hepatol Gastroenterol 2017; 41(2):123-125
    • Morzyglod, L., Cauzac, M., Popineau, L., Denechaud, P. D., Fajas, L., Ragazzon, B., Fauveau, V., Planchais, J., Vasseur-Cognet, M., Fartoux, L., Scatton, O., Rosmorduc, O., Guilmeau, S., Postic, C., Desdouets, C., Desbois-Mouthon, C., Burnol, A. F. Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma Hepatology 2017; 65(4):1352-1368
    • Gentric, G., Maillet, V., Paradis, V., Couton, D., L'Hermitte, A., Panasyuk, G., Fromenty, B., Celton-Morizur, S., Desdouets, C. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease J Clin Invest 2015; 125(3):981-992
    • Sultanik, P., Mallet, V., Lagaye, S., Casrouge, A., Dorival, C., Barthe, Y., Fontaine, H., Hezode, C., Mottez, E., Bronowicki, J. P., Carrat, F., Theodorou, I., Abel, L., Gayat, E., Fontanet, A., Pol, S., Albert, M. L., Anrs, Co Cupic Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy Liver Int 2015; 35(7):1833-44
    • Iroz, A., Couty, J. P., Postic, C. Hepatokines: unlocking the multi-organ network in metabolic diseases Diabetologia 2015; 58(8):1699-703
    • Aoudjehane, L., Bisch, G., Scatton, O., Granier, C., Gaston, J., Housset, C., Roingeard, P., Cosset, F. L., Perdigao, F., Balladur, P., Wakita, T., Calmus, Y., Conti, F. Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C PLoS One 2015; 10(7):e0134141
    • Gentric, G., Desdouets, C. Liver polyploidy: Dr Jekyll or Mr Hide? Oncotarget 2015; 6(11):8430-1
    • Levy, J., Cacheux, W., Bara, M. A., L'Hermitte, A., Lepage, P., Fraudeau, M., Trentesaux, C., Lemarchand, J., Durand, A., Crain, A. M., Marchiol, C., Renault, G., Dumont, F., Letourneur, F., Delacre, M., Schmitt, A., Terris, B., Perret, C., Chamaillard, M., Couty, J. P., Romagnolo, B. Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth Nat Cell Biol 2015; 17(8):1062-73
    • Merlen, G., Gentric, G., Celton-Morizur, S., Foretz, M., Guidotti, J. E., Fauveau, V., Leclerc, J., Viollet, B., Desdouets, C. AMPKalpha1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression J Hepatol 2014; 60(1):152-9
    • Carrat, F., Barthe, Y., Hezode, C., Fontaine, H., Bronowicki, J. P. Reply to: From the CUPIC study: Great times are not coming (?) J Hepatol 2014; 60(1):235-6
    • Godon, O., Fontaine, H., Kahi, S., Meritet, J., Scott-Algara, D., Pol, S., Michel, M., Bourgine, M. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues Mol Ther 2014; 22(3):675-84
    • Pol, S., Vallet-Pichard, A., Corouge, M. Treatment of hepatitis C virus genotype 3-infection Liver Int 2014; 34 Suppl 1:18-23
    • Gentric, G., Desdouets, C. Polyploidization in liver tissue Am J Pathol 2014; 184(2):322-31
    • Trabut, J. B., Thepot, V., Terris, B., Sogni, P., Nalpas, B., Pol, S. [Prognosis assessment of alcoholic liver disease: How and why?] Presse Med 2014; 43(2):124-34
    • Gondeau, C., Douam, F., Lebreton, S., Lagaye, S., Pol, S., Helle, F., Plengpanich, W., Guerin, M., Bourgine, M., Michel, M. L., Lavillette, D., Roingeard, P., le Goff, W., Budkowska, A., Yamamoto, M., Maillard, P., Bocchetta, S. Up-Regulation of the ATP-Binding Cassette Transporter A1 Inhibits Hepatitis C Virus Infection PLoS One 2014; 9(3):e92140
    • Kamar, N., Izopet, J., Tripon, S., Bismuth, M., Hillaire, S., Dumortier, J., Radenne, S., Coilly, A., Garrigue, V., D'Alteroche, L., Buchler, M., Couzi, L., Lebray, P., Dharancy, S., Minello, A., Hourmant, M., Roque-Afonso, A. M., Abravanel, F., Pol, S., Rostaing, L., Mallet, V. Ribavirin for chronic hepatitis E virus infection in transplant recipients N Engl J Med 2014; 370(12):1111-20
    • Obach, D., Deuffic-Burban, S., Esmat, G., Anwar, W. A., Dewedar, S., Canva, V., Cousien, A., Doss, W., Mostafa, A., Pol, S., Buti, M., Siebert, U., Fontanet, A., Mohamed, M. K., Yazdanpanah, Y. Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus-Infected Patients in a Country With Limited Resources: The Case of Egypt Clin Infect Dis 2014; 58(8):1064-71